Strides Pharma Science Limited
Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products.The company's pharmaceutical products are sold in over 100 countries.The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.
What Strides files
- Others53
- Investor Meet35
- Updates32
- Important31
- Board Meeting15
- Dividend/Bonus6
Strides Pharma has set July 31, 2026, as the Record Date for its ₹5/- per share (50%) Final Dividend for FY26. This dividend, previously decided by the Board, is subject to shareholder approval at the AGM on August 14, 2026. Shareholders holding shares by the record date will be eligible...
Strides Pharma Science's Board recently met and approved the financial results for the quarter and full year ended March 31, 2026. The Board also proposed a final dividend of Rs 5 per equity share (50% on Rs 10 face value) for the financial year. This dividend, amounting to approximately Rs...
Strides Pharma Science's Board, after reviewing the financial results for the quarter and financial year ended March 31, 2026, has put forth a final dividend of Rs. 5 per equity share. This shareholder payout totals approximately Rs. 46.1 crore. The company will soon announce the record date for eligible shareholders....
Strides Pharma Science Limited has announced a board meeting on August 7, 2025, for the Annual General Meeting and approval of the final dividend of Rs. 4 per equity share for FY25. The record date for dividend entitlement is July 22, 2025. The dividend will be paid within 30 days...
Strides Pharma Science has announced a final dividend of Rs. 4 per share (40%) for the financial year ended March 31, 2025. Shareholders will receive this payout after approval at the Annual General Meeting, offering a reliable income boost. The dividend will be paid within 30 days post-approval.